Clinical trial

Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol…

NCT00204503 · The University of Texas Medical Branch, Galveston, Other · Withdrawn

Key facts

NCT number NCT00204503
Title Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
Official title An Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence.
Lead sponsor The University of Texas Medical Branch, Galveston, Other
Status Withdrawn
Phase Phase 2
Study type Interventional
Conditions Bipolar I or II Depression and Alcohol Abuse or Dependence
Intervention type Drug
Interventions Depakote ER
Enrollment 0
Start date Jun 1, 2003
Completion May 1, 2005
First posted Sep 20, 2005
Last update posted Mar 31, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies